HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Li Zhu Selected Research

ligustilide

1/2015Ligustilide prevents cognitive impairment and attenuates neurotoxicity in D-galactose induced aging mice brain.
7/2013Z-ligustilide activates the Nrf2/HO-1 pathway and protects against cerebral ischemia-reperfusion injury in vivo and in vitro.
11/2012Ligustilide alleviates brain damage and improves cognitive function in rats of chronic cerebral hypoperfusion.
9/2011Neuroprotective effect of ligustilide against ischaemia-reperfusion injury via up-regulation of erythropoietin and down-regulation of RTP801.
5/2007Ligustilide attenuates pain behavior induced by acetic acid or formalin.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Li Zhu Research Topics

Disease

184Neoplasms (Cancer)
10/2022 - 02/2003
77Breast Neoplasms (Breast Cancer)
09/2022 - 07/2004
46Inflammation (Inflammations)
10/2022 - 05/2005
45Hypoxia (Hypoxemia)
12/2022 - 02/2000
40Infections
10/2022 - 12/2005
33Neoplasm Metastasis (Metastasis)
05/2022 - 06/2004
28IGA Glomerulonephritis (IGA Nephropathy)
06/2022 - 08/2008
21Lung Neoplasms (Lung Cancer)
01/2021 - 03/2003
19Ischemia
01/2022 - 02/2000
18Thrombosis (Thrombus)
11/2022 - 01/2006
18Fibrosis (Cirrhosis)
01/2022 - 12/2004
14Obesity
04/2022 - 01/2012
14Alzheimer Disease (Alzheimer's Disease)
01/2021 - 04/2007
14Uterine Cervical Neoplasms (Cancer of the Cervix)
01/2020 - 10/2014
13Insulin Resistance
04/2022 - 08/2008
13Reperfusion Injury
01/2022 - 01/2007
13Hypertension (High Blood Pressure)
01/2022 - 01/2014
13Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
12/2019 - 02/2003
11Atherosclerosis
01/2022 - 07/2009
11Carcinoma (Carcinomatosis)
10/2021 - 11/2003
10Cardiovascular Diseases (Cardiovascular Disease)
07/2022 - 07/2004
10Body Weight (Weight, Body)
06/2022 - 12/2011
10Hepatocellular Carcinoma (Hepatoma)
04/2022 - 06/2003
10COVID-19
01/2022 - 01/2020
10Proteinuria
01/2022 - 12/2009
10Stomach Neoplasms (Stomach Cancer)
01/2022 - 12/2005
10Leukemia
12/2021 - 09/2008
10Type 2 Diabetes Mellitus (MODY)
12/2021 - 10/2010
10Heart Failure
01/2021 - 01/2012
10Squamous Cell Carcinoma of Head and Neck
01/2021 - 10/2005
10Neurodegenerative Diseases (Neurodegenerative Disease)
12/2020 - 02/2005
9Lymphatic Metastasis
01/2022 - 12/2006
9Carcinogenesis
06/2021 - 01/2004
8Stroke (Strokes)
01/2022 - 01/2013
8Coronary Disease (Coronary Heart Disease)
01/2022 - 01/2015
8Atrial Fibrillation
01/2022 - 01/2015
8Atherosclerotic Plaque (Atheroma)
01/2021 - 07/2008
7Pneumonia (Pneumonitis)
08/2022 - 07/2011
7Ovarian Neoplasms (Ovarian Cancer)
12/2021 - 10/2009
7Pain (Aches)
10/2021 - 11/2006
7Metabolic Syndrome (Dysmetabolic Syndrome X)
01/2021 - 04/2014
7Brain Ischemia (Cerebral Ischemia)
11/2020 - 11/2010
7Melanoma (Melanoma, Malignant)
09/2020 - 08/2013

Drug/Important Bio-Agent (IBA)

83Proteins (Proteins, Gene)FDA Link
12/2022 - 02/2000
41Biomarkers (Surrogate Marker)IBA
10/2022 - 12/2003
32Messenger RNA (mRNA)IBA
10/2022 - 01/2004
32MicroRNAs (MicroRNA)IBA
10/2022 - 02/2011
26Pharmaceutical PreparationsIBA
10/2022 - 09/2005
25Biological ProductsIBA
10/2022 - 01/2010
20CytokinesIBA
08/2022 - 06/2004
17Glucose (Dextrose)FDA LinkGeneric
04/2022 - 11/2004
17Oxygen (Dioxygen)IBA
01/2022 - 11/2004
17LigandsIBA
01/2022 - 12/2003
16Immunoglobulin A (IgA)IBA
03/2022 - 10/2007
14Long Noncoding RNAIBA
10/2022 - 01/2015
14Estrogen ReceptorsIBA
09/2022 - 10/2015
14DNA (Deoxyribonucleic Acid)IBA
01/2022 - 12/2005
14VaccinesIBA
01/2022 - 07/2005
13Hormones (Hormone)IBA
09/2022 - 08/2008
12Insulin (Novolin)FDA Link
10/2022 - 06/2003
12Cisplatin (Platino)FDA LinkGeneric
11/2021 - 10/2005
11Therapeutic UsesIBA
07/2022 - 09/2006
11Transcription Factors (Transcription Factor)IBA
04/2022 - 06/2005
11Peptides (Polypeptides)IBA
01/2022 - 03/2003
10Small Interfering RNA (siRNA)IBA
10/2022 - 01/2009
10Reactive Oxygen Species (Oxygen Radicals)IBA
08/2022 - 05/2005
10Interleukin-6 (Interleukin 6)IBA
08/2022 - 12/2008
10LipidsIBA
04/2022 - 07/2009
10EnzymesIBA
01/2022 - 10/2010
10IronIBA
11/2021 - 03/2006
10Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
01/2019 - 01/2006
10Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
09/2015 - 02/2000
9AntigensIBA
03/2022 - 05/2017
9Phosphotransferases (Kinase)IBA
01/2022 - 09/2007
9Indicators and Reagents (Reagents)IBA
01/2022 - 06/2011
8human ERBB2 proteinIBA
09/2022 - 06/2017
8Complement System Proteins (Complement)IBA
06/2022 - 09/2015
8L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA
01/2022 - 08/2005
8Chimeric Antigen ReceptorsIBA
01/2022 - 01/2019
8AntibodiesIBA
01/2021 - 08/2004
8Phenobarbital (Luminal)FDA Link
01/2021 - 01/2014
8Cyclooxygenase 2 (Cyclooxygenase-2)IBA
10/2009 - 02/2003
7CollagenIBA
08/2022 - 05/2002
7MicellesIBA
08/2022 - 10/2019
7InflammasomesIBA
07/2022 - 01/2018
7Semaphorins (Semaphorin)IBA
01/2022 - 07/2009
7RNA (Ribonucleic Acid)IBA
01/2022 - 01/2019
7HMGB1 Protein (HMG1)IBA
01/2022 - 01/2016
7ErbB Receptors (EGF Receptor)IBA
01/2022 - 09/2006
7AlbuminsIBA
01/2022 - 02/2000
7Interleukin-10 (Interleukin 10)IBA
07/2021 - 12/2003
7Circular RNAIBA
01/2021 - 01/2018
7ErythropoietinFDA Link
01/2017 - 02/2007

Therapy/Procedure

74Therapeutics
08/2022 - 02/2004
37Drug Therapy (Chemotherapy)
10/2022 - 10/2005
22Radiotherapy
01/2022 - 12/2006
14Neoadjuvant Therapy
01/2022 - 07/2004
13Adjuvant Chemotherapy
06/2022 - 09/2012
11Immunotherapy
01/2022 - 11/2003
8Chinese Traditional Medicine (Traditional Chinese Medicine)
01/2022 - 11/2012